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Purpose. To investigate the sensitivity of mesenteric angiography, technical success of hemostasis, clinical success rate, and
complications of transcatheter embolization for the treatment of acute nonvariceal gastrointestinal hemorrhage. Material and
Methods. A retrospective review of 200 consecutive patients who underwent mesenteric arteriography for acute nonvariceal
gastrointestinal hemorrhage between February 2004 and February 2011 was done. Results. Of 200 angiographic studies, 114 correctly
revealed the bleeding site with mesenteric angiography. 47 (41%) patients had upper gastrointestinal hemorrhage and 67 (59%)
patients had lower gastrointestinal hemorrhage. Out of these 114, in 112 patients (98%) technical success was achieved with
immediate cessation of bleeding. 81 patients could be followed for one month. Clinical success was achieved in 72 out of these
81 patients (89%). Seven patients rebled. 2 patients developed bowel ischemia. Four patients underwent surgery for bowel ischemia
or rebleeding. Conclusion. The use of therapeutic transcatheter embolization for treatment of acute gastrointestinal hemorrhage is
highly successful and relatively safe with 98% technical success and 2.4% postembolization ischemia in our series. In 89% of cases
it was definitive without any further intervention.

1. Introduction
Acute gastrointestinal (GI) hemorrhage is a commonly
presenting medical emergency having a hospital mortality
of around 10% [1]. Presentation may vary from insidious
blood loss to potentially life-threatening hemorrhage [2].
The bleeding site determination is challenging as it involves
entire gastrointestinal tract [2]. Upper gastrointestinal hemorrhage patients present with hematemesis or melena and
the bleeding point is proximal to the ligament of Treitz,
whereas gastrointestinal lower haemorrhage patients present
with melena or hematochezia and bleeding point is distal to
the ligament of Treitz [3–5]. Bleeding ceases spontaneously
in approximately 75% of cases and can recur in 25% of cases,
resulting in significant morbidity and mortality [6].
Therapeutic options available for patients with acute
GI hemorrhage include conservative medical management,
endoscopic coagulation, vasopressin infusion, therapeutic
transcatheter embolization, and surgery [7, 8]. Endoscopy
is considered as a first-line diagnostic and therapeutic

procedure; its sensitivity reaches 100% in upper gastrointestinal bleed but in case of lower gastrointestinal bleed
only probable bleeding source can be found (60% of cases).
In stable patients, radionuclide and CT imaging plays a
great role. Tc-99m RBC scintigraphy is more than 90%
sensitive and specific in detecting a bleeding site anywhere
in gastrointestinal tract. However, its limited resolution does
not allow precise gastrointestinal bleed localization.
Endoscopy can fail in approximately 32% of cases because
of presence of stool, blood clots, and technical difficulties as
time required for patient’s preparation for colonoscopy [9].
In addition, bleeder source in small bowel is not accessible
via colonoscope [10]. Significant morbidity and mortality
are associated with emergency surgery [11]. Higher rates of
complication and rebleeding were encountered in patients
treated with vasopressin [12]. Nusbaum and Baum first
described mesenteric angiography for acute GI hemorrhage
in 1963 [13]. In 1972, Rösch et al. successfully controlled acute
gastric hemorrhage by gastroepiploic artery embolization
using autologous blood clot [14]. Due to significant technical
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improvements in the past 10 years selective therapeutic
transcatheter embolization has become a safer procedure and
is now widely used for acute GI hemorrhage management
[15].
The purpose of our study was to investigate the sensitivity
of mesenteric angiography, technical success of hemostasis,
clinical success rate, and complications of therapeutic transcatheter embolization for the treatment of acute nonvariceal
gastrointestinal hemorrhage.

2. Materials and Methods
2.1. Study Group. We performed a single-center (from February 2004 to February 2011) retrospective survey of all patients in whom therapeutic transcatheter embolization was
attempted for control of acute gastrointestinal bleeding.
2.2. Patient Selection. All acute GI hemorrhage patients who
underwent mesenteric angiograms during this period were
enrolled. These patients had been referred to by abdominal
surgeons, emergency room (ER) physicians, or gastroenterologists, and procedures were performed by experienced
interventional radiologist.
2.3. Clinical Data. The clinical and laboratory data, imaging and endoscopic findings, and care provided as well as
the outcome data were obtained from medical records of
our hospital. The following parameters were collected for
each patient: age, gender, presenting symptoms, severity of
hemorrhage, site of bleeding, comorbid, number of units
of blood or packed red blood cells transfused, history of
coagulation disorder, and findings of prior endoscopy or
scintigraphy. Angiographic characteristics include segmental
localization of bleeding in the gastrointestinal tract, vascular territory which is corresponding, catheters used for
embolization, technique of embolization whether selective
(proximal) or superselective (distal), repeat angiographic
procedures, and type of embolic agent(s) used. Complications
were divided into intraoperative and postprocedural complications. Follow-up duration as well as conservative or surgical
management of complications was also documented.
2.4. Angiography and Embolization. Celiac, superior mesenteric, and inferior mesenteric angiography was performed
transfemorally using 4 Fr or 5 Fr Cobra or Simmons type
catheters (Cordis). Selective SMA angiography was also
done by advancing catheter in different branches to evaluate
the jejunal, ileal, ileocolic, and colic branches. Once the
bleeding site was determined, then superselective catheterization was usually performed using a 2.7 Fr microcatheter
(Progreat-Terumo), which is inserted coaxially through the
macrocatheter. Superselective embolization was attempted
by positioning the catheter as close to the bleeding site
as possible. The materials used for embolization included
microcoils (Cook and Balt), gelfoam, and polyvinyl alcohol
particles (Boston Scientific). Other than active bleeding
or pseudoaneurysm indirect sign for abnormal site was
described when there were arteriovenous fistula vascular tuft,
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early filling vein, or a hyper vascular mass. In certain cases
where there was endoscopic finding of active bleeding from
duodenal region and a negative arteriography, a prophylactic
embolization of the gastroduodenal artery was performed
using Sandwich technique. In this the catheter is placed distal
to the bleeding site followed by placement of coil, and then
the catheter is withdrawn proximal to the bleeding site with
deployment of another coil to sandwich the bleeding point
in between. This technique ensures any retrograde filling of
the targeted portion of the vessel embolized. In few cases with
severe vasospasm intra-arterial nitroglycerine was also given.
All procedures were performed by vascular access at
the level of the common femoral artery using 5 Fr vascular
access sheath (Arrow, Medcomp). Postexamination, manual
compression was maintained at puncture site with the patient
lying in supine position for hemostasis.
2.5. Definition and Data Analysis. Successful embolization is
termed when there is devascularization of a focal lesion or
reduction or stoppage of flow to the vascular bed. We defined
outcome criteria in accordance with the guidelines of the
Society of Interventional Radiology (SIR) [16].
Technical success was described as immediate cessation
of extravasation on postprocedure angiography [16].
Clinical success was described as nonoccurrence of bleed
or hemodynamic instability within 30 days after embolization
on follow-up evaluation. Monitoring was performed to evaluate signs and symptoms of intestinal infarction or ischemia
[16].
Rebleeding was described as drop in hemoglobin >1 g/dL
in the presence of overt GI hemorrhage within 30 days. An
ischemic event was defined as bowel ischemia or infarction
that required surgery [16].
Data was entered into SPSS statistical software version
19.0. Mean and standard deviations were computed for
quantitative variables. Frequencies and descriptive analysis of
the variables also measured.

3. Results
From February 2004 until February 2011, a total of 200
patients underwent mesenteric angiography for acute GI
hemorrhage at our institution. 114 patients (57%) had contrast
blush or abnormal vascularity in the GI tract and underwent
therapeutic transcatheter embolization.
There were 134 (67%) male and 66 (33%) female patients
with male-to-female ratio of 2 : 1. Median age was 57 years
(range: 8–97 years).
28 patients present with hematemesis, 66 with melena,
and 106 with per-rectal bleeding. Severity of the symptoms
was also calculated which were mild (𝑛 = 74), moderate
(𝑛 = 96), and severe (𝑛 = 30). These are summarized in
Table 1.
We also evaluated the effect of associated comorbid
conditions which predispose to GI hemorrhage. 44 patients
had no comorbid disease, 28 had infectious disease, 24 had
chronic liver disease, 22 had hypertension, 15 had diabetes
mellitus, 20 had chronic renal disease, 21 had malignancy,
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Table 1: Demographics and characteristics of 200 patients who had
mesenteric angiogram for acute GI hemorrhage.
Characteristics
Angiographic sensitivity
Median age
Gender
Male
Female
Presenting complaints
Hematemesis
Melena
Perrectal bleeding
Prior investigation
Upper GI endoscopy
Positive
Negative
RBC-tagged scintigraphy
Positive
Negative
Prior blood transfusion
Coagulation profile
Normal
Deranged
Comorbid
No comorbid
Chronic liver disease
Hypertension
Diabetes mellitus
Chronic renal failure
Malignancy
Trauma
Infectious diseases
Misc

Results
114 (57%)
55 years
134 (76%)
66 (33%)
28 (14%)
66 (33%)
106 (53%)
93
66 (71%)
27 (29%)
62
49 (79%)
13 (21%)
145 (72.5%)
124 (62%)
76 (38%)
44 (22%)
24 (12%)
22 (11%)
15 (7.5%)
20 (10%)
21 (10.5%)
10 (5.0%)
28 (14%)
16 (8.0%)

10 had trauma, and 16 patients had miscellaneous comorbid
diseases.
Blood was transfused in 145 (72.5%) out of 200 patients.
Coagulation profile was deranged in 76 (38%) patients; the
rest presented with a normal coagulation profile.
Prior RBC-tagged scintigraphy was performed in 62
patients. In 49 (79%) it showed activity corresponding to
bleeding site. Majority of these patients had lower GI haemorrhage. Endoscopy was also performed in 93 patients of which
66 (70.9%) were positive.
On mesenteric angiography 47 patients (41%) had upper
gastrointestinal hemorrhage, whereas 67 (59%) had lower
gastrointestinal hemorrhage.
Angiographically positive sites were stomach 10 (8.8%),
duodenum 37 (32.5%), jejunum 9 (7.9%), ileum 10 (8.8%),
caecum 29 (25.4%), ascending colon 8 (7.0%), transverse
colon 1 (0.9%), descending colon 2 (1.8%), and rectosigmoid
region 8 (7.0%).
Embolization was technically possible in 112 of 114
patients, reaching a technical success rate of 98.24%. In one

patient technical failure was due to inability to catheterize
the supplying artery. This patient had blunt abdominal
trauma and presented with a large pseudoaneurysm filling
from the inferior pancreaticoduodenal artery. After selective
catheterization of the superior mesenteric artery multiple
collateral vessels was seen at the origin of inferior pancreaticoduodenal artery with retrograde filling of gastroduodenal
artery. Despite multiple attempts the collaterals supplying
the pseudoaneurysm could not be catheterized. The second
patient was a young woman who presented with per-rectal
bleeding. Angiogram demonstrated an abnormal lesion in
the rectum filling in the venous phase. There were multiple
phleboliths suggesting venous hemangioma. Findings were
discussed with referring surgeon and it was decided not to
embolize this lesion due to low vascularity and risk of bowel
ischemia.
Arteries primarily embolized were the gastroduodenal
artery (𝑛 = 36) Figure 1, ileocolic artery (𝑛 = 28) Figure 2,
right colic artery (𝑛 = 12), jejunal branches of superior
mesenteric artery (𝑛 = 10), left gastric artery (𝑛 = 9), superior
rectal artery (𝑛 = 7), ileal braches of superior mesenteric
artery (𝑛 = 5), left colic artery (𝑛 = 4), and middle colic artery
(𝑛 = 1).
We also evaluated the catheters used for angiography.
In 109 (54.5%) patients microcatheter was used, whereas in
91 (45.4%) angiography was performed with regular 4 Fr
catheters. Cobra catheter was used in 174 patients while
Simmons catheter was used in 26 patients.
The type of embolic material used was at the discretion of
the interventional radiologist, and in few patients materials
were used in combination. Microcoils were used in isolation
in 69 patients (62%) and in combination with particles in 9
patients (8%). Particles were used in isolation in 33 patients
(29%) and gel foam was used in 1 patient (0.9%).
Out of 114 patients 81 were followed up with for one
month, 17 for 1 week, and 1 for 1 day while 15 patients were
lost to followup. Hence clinical success was measured in only
81 patients.
Total clinical success in the 30-day followup (i.e., complete resolution of signs or symptoms that prompted the
embolization procedure) was achieved in 72 of 81 patients
(89%). Seven out of 81 patients (11.5%) experienced clinical
signs of early rebleeding Table 2. Corresponding vessels were
gastroduodenal artery (𝑛 = 3), Jejunal branches of SMA
(𝑛 = 2), and a single case from right ileocolic and left
gastric arteries each. In 6 of them repeat angiographies
were done, but only one patient showed recurrent jejunal hemorrhage and underwent clinically successful repeat
embolization.
The only major complication was early bowel ischemia
experienced by 2 (2.4%) of the 81 patients. An elderly male
was presented with perrectal bleeding. Arteriography showed
abnormal vascularity in the territory of superior rectal artery
which was partially embolized using PVA particles. He developed postembolization ischemia along with thrombosis of
right common iliac vein. He underwent urgent rectosigmoid
resection, while limb ischemia was successfully managed
conservatively with oral anticoagulants. Second patient was
an elderly male with bleeding duodenal ulcer on endoscopy.

4
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(a)

(b)

Figure 1: (a) Selective arteriogram of gastroduodenal artery demonstrates active bleeding from superior pancreaticoduodenal branch. (b)
Postembolization arteriogram showed complete exclusion of the bleeding vessel by multiple platinum coils.

(a)

(b)

Figure 2: (a) Selective ileocolic artery angiogram demonstrates intraluminal extravasation of contrast in caecum. (b) Postembolization
arteriogram after selective embolization shows total occlusion of feeding vessel and cessation of hemorrhaging.

His empiric embolization of gastroduodenal artery was done.
He presented with symptoms of ischemia after three days and
was managed conservatively (Table 3).
After embolization 4 patients underwent surgery 3 for
recurrent bleeding and 1 for ischemia. No patient died as a
consequence of complications caused by the procedure.

4. Discussion
Our data supports the present literature in demonstrating
the efficiency of therapeutic transcatheter embolization in
curing acute GI bleeding [5, 17]. In a recently published international consensus recommendation, arterial embolization
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Table 2: Characteristics of 81 patients after one-month followup.
Characteristics
Clinical success
Complication (bowel ischemia)
Rebleeding
Repeat procedure
Surgical management

Results
72 (89%)
02 (2.4%)
07 (8.6%)
06 (7.4%)
04 (4.9%)

Table 3: Characteristics of 114 patients who revealed bleeding site
and underwent therapeutic embolization.
Characteristics
Technical success
Site
Upper GI hemorrhage
Lower GI hemorrhage
Embolization
Proximal (selective)
Distal (superselective)
Arteries embolized
Gastroduodenal artery
Ileocolic artery
Right colic artery
Jejunal branches of SMA
Left gastric artery
Superior rectal artery
Ileal branches of SMA
Left colic artery
Middle colic artery
Embolization material
Microcoils
PVA particles
PVA with microcoils
Gel foam

Results
112 (98%)
47 (41%)
67 (59%)
21 (19%)
91 (81%)
36 (32%)
28 (25%)
12 (11%)
10 (8.9%)
09 (8.0%)
07 (6.2%)
05 (4.4%)
04 (3.6%)
01 (0.9%)
69 (62%)
33 (29%)
09 (8.0%)
01 (0.9%)

is considered as a surgical alternative in upper GI bleeding
management in whom endoscopic haemostatic procedure
has failed or who had recurrent bleeding [16]. Similarly
arterial embolization is now considered a first-line therapy for
patients with severe lower GI bleeding [18].
The first objective of arteriography is to identify the
bleeding site which requires the patient to be actively bleeding
[19, 20]. In few patients even a detailed workup may fail
to identify an exact bleeding site, which resulted in the
patients undergoing repeated blood transfusions and invasive
investigations [20]. In our study 57% of the angiographies
were positive. Charbonnet et al. [2] reported a positive rate of
37% while survey by Zuckerman and Prakash [9] found that
the rate of positive angiograms can vary from 27% to 77%.
Chevallier and colleagues [21] reported very high percentage
(93.4%) of positive angiographies which can be explained by
the increased frequency of superselective catheter placement
in these patients. Nevertheless an angiography may give
normal results despite superselective catheterization because
even a massive hemorrhage can be intermittent [4]. In these

cases a blind or empirical embolization can be done, however,
it is associated with an increased chance of rebleeding and
ischemia [5, 7, 8]. To increase the positive rate prior to
endoscopy, Tc 99 RBC-tagged scintigraphic evaluation or
contrast enhanced CT scans could be helpful in identifying
the bleeding vessel [6, 10, 20].
In our study prior Tc 99 RBC-tagged scintigraphy was
performed in 62 patients with acute GI hemorrhage of which
49 (79%) were positive and helped in the identification of
bleeding site. Similarly, endoscopy was performed in 93
patients of whom 66 (66%) were positive and guide towards
the bleeding vessel.
Endoscopy for the management of gastrointestinal bleed
still remains a feasible option whenever possible. Endoscopy
can be diagnostic as well as therapeutic especially in upper GI
bleed; however, in cases with massive GI bleed visualization
becomes challenging and technically difficult. For lower GI
bleed the technical success of endoscopy also depends on
bowel preparation for optimal visualization. Evaluation of
small bowel loops with endoscopy is not possible. For those
patients in whom endoscopy was inconclusive or failed due to
reasons described therapeutic transcatheter embolization is
considered useful option. Surgery is rarely used for treatment
of upper GI bleeds; however, it is still utilized for management
of lower GI bleeds where endoscopic and transcatheter
embolizations have failed or were not available. MDCT angio
is considered as the initial radiological investigation as it is
a very simple technique. It still requires active bleeding at
the time of imaging but may be repeated in case of the first
negative examination. A positive MDCT angio can select
appropriate patients for rapid targeted embolization. The
visualization of active extravasation of IV contrast in the GI
tract requires careful attention to technique, including thin
collimation, rapid IV contrast administration, and appropriate scan timing. The addition of multiplanar reconstructions
(MPR) and 3D imaging is beneficial in identifying the exact
source of the bleeding.
The present review, with a technical success rate of 98%,
is concurrent with many other reports quoting technical
success of more than 90% [4, 5, 8]. Defreyne and colleagues
[22] reported technical success rate of 98%, while in a recent
study Tan et al. [4] reported a technical success of 97%. In
the literature only few technical failures have been reported,
and they were mainly due to difficult vascular anatomy,
vascular stenosis, and vascular spasms [15, 19]. In few cases
intermittent contrast material extravasation can occur which
reflects spontaneous bleeding arrests [22]. In such cases,
the main arterial trunk should be vigorously studied to
determine the point for safe embolization [3, 15, 22]. Because
active extravasation was initially localized, we did not find
indication for the use of anticoagulants or fibrinolytics, as
recommended by some authors [22, 23].
There is a certain risk of complications with reported
rates of major ischemic complications range from 0% to
16% [23, 24]. Very low rate (2.4%) of bowel ischemia in
our study indicates that we delivered the right amount of
embolic material in most of the cases. Luc Defreyne in 2001
observed absence of bowel ischemia in 40 patients [22]. Aina
and colleagues [24] reviewed 75 consecutive patients who
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underwent arterial embolization for upper GI bleeding and
reported a 99% technical success with a primary clinical
success rate of 76%. Only three cases (4%) of ischemia were
noted, two involving the duodenum and one the liver [24].
In our study rate of rebleeding was 8.6%. The reported
rebleeding rate after therapeutic transcatheter embolization
is approximately 33% (range: 9%–66%) [4]. Kwak et al. [5]
found rebleeding in 21% of the patients while Wong and
colleagues [11] reported high rate of rebleeding (34.4%).
A possible explanation for the high rebleeding rate may
be coiling the gastroduodenal artery from the celiac axis
in these series as gastroduodenal artery can be later fed
with collateral branches from the superior mesenteric artery
[1, 11]. Our study also concurred with these results as 5
(38%) of the patients showed rebleeding from gastroduodenal
artery. A sandwich technique can be used in these cases in
which the gastroduodenal artery was coiled in a distal-toproximal manner [1, 15]. Similarly inflammatory or ischemic
reactions after embolization can trigger vasodilatation of the
intramural collaterals and early rebleeding [12].
Our study had certain limitations, including the fact that
it was a retrospective analysis, and the refinement and clinical
validation of angiographic embolization require a prospective
study. Secondly series of patients were enrolled from a single
institution, and the cause of bleeding was not known in all
cases.
In conclusion, therapeutic transcatheter embolization for
the treatment of acute gastrointestinal hemorrhage is highly
successful and relatively safe procedure with high technical
and clinical success rates, and it should be reserved as a
treatment option for patients who are high risk for surgery
and failed endoscopic and medical management.
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